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Nuclear Receptors: [LRH-1](http://www.nursa.org/molecule.cfm?molType=receptor&molId=5A2).

The hypothalamic neuropeptide kisspeptin is a master regulator of the hypothalamic-pituitary-gonadal axis ([@B1], [@B2]). Mutations in the *Kiss1* gene result in infertility in mice and humans ([@B3]--[@B7]). Kisspeptin is synthesized in neurons in two regions of the hypothalamus: the arcuate nucleus (Arc) and the anteroventral periventricular nucleus (AVPV) ([@B8], [@B9]). Secretion of kisspeptin activates its cognate G protein-coupled receptor, GPR54, on GnRH neurons, which direct the pituitary to release FSH and LH ([@B10]--[@B16]). During diestrus, kisspeptin secreted from the Arc stimulates the release of FSH required for ovarian follicles to mature. During proestrus, follicle maturation concludes and follicular secretion of estradiol (E~2~) peaks. E~2~, in turn, has two important downstream effects. First, it induces *Kiss1* expression in the AVPV by activating the estrogen receptor α (ERα). This causes a surge in pituitary LH secretion, which triggers ovulation of the mature follicles. Second, E~2~ represses *Kiss1* expression in the Arc, also through an ERα-dependent mechanism. The importance of ERα in coordinating this reproductive cycle is demonstrated by the infertility and polycystic ovarian phenotype that occur in mice selectively lacking ERα in kisspeptin neurons ([@B17]). Although it is well established that the AVPV pool of kisspeptin neurons dictates the timing of the LH surge needed for ovulation, it is unknown how *Kiss1* expression is maintained in the Arc during diestrus.

Liver receptor homolog-1 (LRH-1; NR5A2) is a nuclear receptor that regulates lipid and sterol metabolism in enterohepatic tissues, steroid synthesis in the ovary, and digestive enzyme expression in the exocrine pancreas ([@B18], [@B19]). LRH-1 is involved in coordinating the actions of endocrine signaling axes across multiple tissues. For example, in the intestine and liver, LRH-1 governs a transcriptional network of genes involved in bile acid signaling, including the hormone fibroblast growth factor 15/19 ([@B20]--[@B24]). Likewise, in the reproductive axis, LRH-1 acts in multiple tissues including the pituitary and gonads to coordinately regulate genes involved in gonadotropin and steroid hormone synthesis ([@B25], [@B26]).

Although LRH-1 expression has been observed in the human and mouse Arc ([@B27], [@B28]), its role there has not been established. Here, we report that LRH-1 is expressed in kisspeptin neurons of the Arc but not in the AVPV. We further show that LRH-1 maintains *Kiss1* expression in the Arc at the level required for normal FSH secretion and follicle maturation.

Materials and Methods
=====================

Mouse studies
-------------

All animal experiments were approved by the Institutional Animal Care and Research Advisory Committee of the University of Texas Southwestern Medical Center. *Lrh1^Kiss1^*^−/−^ mice were generated using previously described mouse lines ([@B24], [@B29]). *Npy-Egfp, Pomc-Egfp*, and *Kiss1-Egfp*/*Kiss1*-β*gal* mice were as described elsewhere ([@B24], [@B29]). To generate the kisspeptin neuron-specific *Lrh1*-transgenic line, a lox-stop-lox-*Lrh1*-Tg mouse was constructed by standard transgenic techniques and crossed with the *Kiss1-Cre* line. All mice were maintained on a mixed C57 BL/6J × 129/Sv background and littermates were used in all experiments.

To determine the effect of E~2~ on hypothalamic *Kiss1* expression, mice underwent ovariectomy followed by E~2~ replacement. After recovering from surgery, mice were injected sc at 3:00 [pm]{.smallcaps} with either vehicle (100% ethanol), or 6 μg 17β-E~2~ (Sigma Chemical Co, St Louis, Missouri) as previously described ([@B30], [@B31]). Mice were humanely destroyed 24 hours after injection.

The stage of the estrous cycle was determined daily at 3:00 [pm]{.smallcaps} via vaginal lavage and microscopic examination of vaginal epithelial cell morphology ([@B32], [@B33]). For tissue collection, mice verified to be in diestrus or estrus, were humanely destroyed via isoflurane overdose at 3:00 [pm]{.smallcaps}. To assess fertility, *Lrh1^fl/fl^* and *Lrh1^Kiss1^*^−/−^ mice were housed with proven stud males and monitored for litter frequency for at least 4 months. Tissues were snap frozen in liquid nitrogen and stored at −80°C or processed for histologic analysis. To induce superovulation, adult mice in diestrus were injected ip with 5 IU gonadotropin from pregnant mare serum (Sigma) followed 48 hours later by ip injection of 5 IU human chorionic gonadotropin (Sigma). Ovaries were harvested 24 hours later.

Plasma analysis
---------------

Plasma levels of FSH and LH were measured at the University of Virginia Ligand Core Laboratory (Charlottesville, Virginia).

Histology and in situ hybridization
-----------------------------------

For ovarian histology, hematoxylin staining was performed on 5-μm sections that were cut in series at 100-μm intervals throughout the entire ovary. In situ hybridization with a 500-bp riboprobe specific to the 3′-untranslated region of LRH-1 was performed as described previously ([@B34]).

Fluorescence-activated cell sorting
-----------------------------------

Fluorescence-activated cell sorting collection and analysis of neurons were performed as described elsewhere ([@B29]). RNA extraction was performed using the PicoPure RNA Isolation kit (Arcturis, St Louis, Missouri). Before quantitative PCR (QPCR), cDNA was preamplified using 2× TaqMan PreAmp Master Mix (Applied Biosystems, Foster City, California).

QPCR analysis
-------------

QPCR was conducted as described previously ([@B35], [@B36]). Primer sequences are available upon request.

Chromatin immunoprecipitation (ChIP)
------------------------------------

ChIP analysis of the *Kiss1* promoter from Arc of female mice in diestrus collected at 3:00 [pm]{.smallcaps} was performed using a Magna Chip-G Tissue kit (Millipore Corp, Bedford, Massachusetts) according to manufacturer\'s directions. Antihuman LRH-1 mouse monoclonal antibody (Perseus Proteomics, Tokyo, Japan; PP-H2325--00, lot A2) was used for ChIP of LRH-1 on the *Kiss1* promoter. Primer sequences for ChIP were: −4325: forward, 5′-AGCCTGTTTCTGCCCTTCA-3′; reverse, 5′-GGCTTTGAGACAGCAGATGTG-3′−4142: forward, 5′-AAAGCTCCGCCTGCCTTA-3′; reverse, 5′-GGTGGCACATTCCTCCAAT-3′−3797: forward, 5′-CCGGTCTCAGCTCACAGTACA-3′; reverse, 5′-AAGAAAGCCAGGTCAGATTGG-3′−2400: forward, 5′-GGAGTTGGTTTTTCCCCTTCT-3′; reverse, 5′-CGCTTGACAATCTGAATTTAATCC-3′−1110: forward, 5′-CCTAGGCTCCACCTGTTGTG-3′; reverse, 5′-CCCAACAAATGGCATTAAGTG-3′+196: forward, 5′-GGCTGGTCTAGGCCCTTCT-3′; reverse, 5′-ACAGGACCCCCAACTCTAGCT-3′+427: forward, 5′-CCATCCCAGCACTTGGAA-3′; reverse, 5′-TGTCCTGGACCAGGCTGAT-3′+766: forward, 5′-CCCCCCAAGAGCATCATG-3′; reverse, 5′-CGAACAGCCAAGAAGAATTCA-3′+1034: forward, 5′-GGCCACACTCACCTCCAA-3′; reverse, 5′-GCGGAGGATGGCTTTGA-3′

Plasmids and reporter constructs
--------------------------------

Various lengths of the *Kiss1* promoter isolated from purified C57 BL/6J mouse genomic DNA were cloned into a pGL4-*Luc2* vector (Promega Corp, Madison, Wisconsin) using standard cloning techniques. Mutational insertions were generated with a QuikChange II LX site-directed mutagenesis kit (Stratagene, La Jolla, California). The *Lrh1* cDNA sequence was cloned into the multiple cloning site in the CAG-Z-multiple cloning site-IRES-*Egfp* vector using standard techniques.

Cell-based reporter assays
--------------------------

Cell culture and cotransfection assays were performed in phenol-red free DMEM as described elsewhere ([@B37]).

Statistical analysis
--------------------

Microsoft Excel 2007 was used for statistical analysis of data. Student\'s test of *P* \< .05 was considered significant when comparing two groups.

Results
=======

*Lrh1* mRNA expression in the central nervous system was previously shown to be highest in the Arc ([@B27], [@B28]). Consistent with these findings, we detected *Lrh1* mRNA in the Arc but not the AVPV of dissected female mouse hypothalami by quantitative (Q) PCR ([Figure 1](#F1){ref-type="fig"}A). To determine whether *Lrh1* is expressed in kisspeptin, neuropeptide Y, or proopiomelanocortin neurons in the Arc, we used three different reporter mouse lines in which enhanced green fluorescent protein (EGFP) is selectively expressed in these different neuron populations ([@B29]). EGFP^+^ neurons were collected from Arc of female mice using fluorescence-activated cell sorting. Notably, *Lrh1* expression was highly enriched in kisspeptin neurons ([Figure 1](#F1){ref-type="fig"}B).

![LRH-1 Regulates *Kiss1* in Arc Neurons. A, *Lrh1* mRNA levels in dissected samples of AVPV and Arc (n = 10 per group). B, *Lrh1* mRNA levels in EGFP^+^ Arc neurons from *Npy-Egfp*, *Pomc-Egfp*, or *Kiss1-Egfp* mouse lines (n = 6 per group). EGFP-negative neurons were collected as a control. C, *Lrh1* mRNA levels in Arc of *Lrh1^Kiss1^*^−/−^ (knockout \[KO\]) mice and control *Lrh1^fl/fl^* (fl/fl) littermates (n = 8 per group). D and E, *Kiss1* mRNA in Arc (D) or AVPV (E) of female *fl/fl or* KO mice in diestrus and estrus as indicated (n = 8, diestrus; n = 5, estrus). F, Ovariectomy (OVX) or sham surgery followed by either vehicle (Veh) or E~2~ replacement in fl/fl and KO mice (n = 6 per group). Error bars represent SEM. Letters above bars denote statistical significance values by Student\'s *t* test: *a* = *P* \< .05; *b* = *P* \< .01; *c* = *P* \< .005; *d* = *P* \< .001. FACS, fluorescence-activated cell sorting; GFP, green fluorescent protein.](zmg0041351710001){#F1}

To examine the role of LRH-1 in kisspeptin neurons in the Arc, we crossed mice carrying a floxed *Lrh1* allele ([@B24]) with *Kiss1-Cre* mice ([@B29]) to generate kisspeptin neuron-specific *Lrh1* knockout mice (*Lrh1^Kiss1^*^−/−^). Although *Kiss1-Cre* is active as early as day 14.5 during embryonic development (C.F.E, unpublished data, 2012), we did not detect histologic changes in the Arc or any other region of the hypothalamus in *Lrh1^Kiss1^*^−/−^ mice (Supplemental Figure 1A published on The Endocrine Society\'s Journals Online web site at <http://endo.endojournals.org> and data not shown). QPCR analysis showed that *Lrh1* expression was reduced but not eliminated in the Arc of *Lrh1^Kiss1^*^−/−^ mice ([Figure 1](#F1){ref-type="fig"}C). The remaining *Lrh1* expression likely occurs in either kisspeptin neurons that do not express Cre at levels sufficient to drive recombination or in an unidentified Arc neuronal population that expresses *Lrh1* but not *Kiss1. Lrh1* mRNA levels were unchanged in the pituitary, ovary, and other peripheral tissues in *Lrh1^Kiss1^*^−/−^ mice (Supplemental Figure 1, B--D). *Lrh1^Kiss1^*^−/−^ mice did not have changes in body weight or food intake (Supplemental Figure 1E).

We next measured *Kiss1* mRNA levels in Arc samples dissected from female *Lrh1^Kiss1^*^−/−^ mice. *Kiss1* mRNA levels were significantly reduced during diestrus and estrus ([Figure 1](#F1){ref-type="fig"}D). In contrast, *Kiss1* levels were unchanged in the AVPV in the *Lrh1^Kiss1^*^−/−^ mice ([Figure 1](#F1){ref-type="fig"}E).

To test the contribution of LRH-1 to E~2~-mediated repression of *Kiss1* expression in Arc neurons, *Lrh1^Kiss1^*^−/−^ and control mice homozygous for the floxed *Lrh1* allele (*Lrh1^fl/fl^*) were ovariectomized and 2 weeks later given an sc injection of either E~2~ or vehicle alone. As expected, *Kiss1* expression was increased in *Lrh1^fl/fl^* mice after ovariectomy and repressed approximately 2-fold in response to E~2~ ([Figure 1](#F1){ref-type="fig"}F). Likewise, *Kiss1* mRNA levels were increased in ovariectomized *Lrh1^Kiss1^*^−/−^ mice, although to a lower absolute level than in *Lrh1^fl/fl^* mice. Importantly, *Kiss1* was still repressed 2- to 3-fold by E~2~ in *Lrh1^Kiss1^*^−/−^ mice ([Figure 1](#F1){ref-type="fig"}F). Thus, whereas LRH-1 is required for basal *Kiss1* expression in the Arc, it is not required for E~2~-mediated repression of this gene.

To test whether *Kiss1* is a direct LRH-1 target gene, we performed scanning ChIP experiments using Arc tissue from female mice in diestrus. LRH-1 bound to the *Kiss1* promoter at two regions: one approximately 3700 bp upstream of the transcriptional start site (TSS) and another about 200 bp downstream of the TSS in the first intron of the *Kiss1* gene ([Figure 2](#F2){ref-type="fig"}A). Computational inspection of these regions revealed conserved LRH-1 response elements centered at −3130 bp and +204 bp ([Figure 2](#F2){ref-type="fig"}B).

![*Kiss1* Is a Direct LRH-1 Target Gene. A, ChIP for LRH-1 on Arc samples from female mice in diestrus (n = 5). x-Axis labels indicate the binding site of the forward QPCR primer. B, Schematic of the murine *Kiss1* promoter with putative LRH-1 response elements (LRHRE) indicated. C, Schematic of *Kiss1*-luciferase reporter vectors. For p*Kiss1*m204, the mutations in the LRHRE at +204 bp are underlined. D, Transient transfection assays performed with the indicated *Kiss1* promoter-luciferase reporter plasmids in either the presence or absence of an LRH-1 expression vector. E, Transient transfection assays performed with the p*Kiss1*-4057 and p*Kiss1*m204 reporter plasmids in either in the presence or absence of an LRH-1 expression vector. F and G, *Lrh1* and *Kiss1* mRNA levels in Arc (F) or AVPV (G) of the kisspeptin neuron-specific *Lrh1-*transgenic (*Lrh1-*Tg) or control (Con) lox-stop-lox-*Lrh1* mice (n = 4 mice per group). Error bars represent SEM. Student\'s *t* test: *a* = *P* \< .05; *d* = *P* \< .001.](zmg0041351710002){#F2}

To determine the functional significance of the putative LRH-1 binding sites, three luciferase reporter constructs containing differing lengths of the 5′-*Kiss1* promoter were generated ([Figure 2](#F2){ref-type="fig"}C) and cotransfected in the absence or presence of an LRH-1 expression vector into HEK293 cells. LRH-1 stimulated reporter activity from the −4057/+455*Kiss1* construct containing both the −3130-bp and +204-bp sites by approximately 2-fold ([Figure 2](#F2){ref-type="fig"}D). Reporter plasmids containing the *Kiss1* promoter truncated to −2185 bp or −205 bp upstream of the TSS showed reporter activity identical to that of the −4057*Kiss1* construct ([Figure 2](#F2){ref-type="fig"}D). To test whether the +204-bp site was responsible for the induction of *Kiss1* promoter activity, a reporter plasmid was constructed in which this site was mutated (p*Kiss*1m204; [Figure 2](#F2){ref-type="fig"}C). LRH-1 had no activity on p*Kiss*1m204 ([Figure 2](#F2){ref-type="fig"}E). These data demonstrate that LRH-1 directly activates the *Kiss1* promoter by binding to the +204-bp site.

To test whether LRH-1 induces *Kiss1* expression in vivo, we generated a *Kiss1*-specific *Lrh1* transgenic mouse line (*Kiss1-Lrh1*-Tg). The transgenic cassette included a CAG viral promoter and a triple-polyA transcriptional stop signal flanked by LoxP sites upstream of the *Lrh1* transgene (Supplemental Figure 2A) ([@B38]). Upon *Cre* induction, LoxP recombination removes the transcriptional stop signal, allowing the CAG promoter to drive *Lrh1* expression. Lox-stop-lox-*Lrh1*-Tg mice were crossed with the *Kiss1-Cre* line to generate the *Kiss1-Lrh1*-Tg line with 4-fold overexpression of *Lrh1* in the Arc ([Figure 2](#F2){ref-type="fig"}F). *Lrh-1* expression was also increased in the AVPV ([Figure 2](#F2){ref-type="fig"}G) but unchanged in the pituitary and ovary of *Lrh1*-Tg mice (Supplemental Figure 2, B and C). Importantly, *Kiss1* levels were increased by nearly 4-fold in Arc samples from *Lrh1*-Tg mice in diestrus ([Figure 2](#F2){ref-type="fig"}F) and also trended higher in the AVPV ([Figure 2](#F2){ref-type="fig"}G). These gain-of-function data complement the knockout data in demonstrating that LRH-1 regulates *Kiss1* in vivo.

We next assessed female reproductive function in *Lrh1^Kiss1^*^−/−^ mice. The age of sexual maturity, as defined by the day of first estrus, was significantly delayed in *Lrh1^Kiss1^*^−/−^ mice ([Figure 3](#F3){ref-type="fig"}A). In addition, adult *Lrh1^Kiss1^*^−/−^ mice cycled less frequently ([Figure 3](#F3){ref-type="fig"}, B and C) and spent more time in diestrus than control mice ([Figure 3](#F3){ref-type="fig"}D). Although female *Lrh1^Kiss1^*^−/−^ mice were fertile, the time between litters was significantly longer than that of control mice ([Figure 3](#F3){ref-type="fig"}E) and they had fewer pups per litter ([Figure 3](#F3){ref-type="fig"}F). Thus, female *Lrh1^Kiss1^*^−/−^ mice have reproductive defects.

![LRH-1 in Kisspeptin Neurons Is Required for Optimal Reproductive Fitness. A, Analysis of the first day of estrus during puberty in *Lrh1^fl/fl^* (fl/fl) and *Lrh1^Kiss1^*^−/−^ knockout (KO) mice (n = 8 per group). B, Representative estrous cycle stage profiles for a fl/fl and KO mouse caged together; C, cornified vaginal epithelia (estrus \[Es\]); N, nucleated vaginal epithelia (proestrus \[Pro\]); L, predominately lymphocytic epithelia (diestrus \[Di\]). C, Average number of estrous cycles per month in fl/fl and KO mice (n = 14 per group). D, Time spent in each stage of the estrous cycle in fl/fl and KO mice for 8 weeks (n = 14 per group). E, Number of days between litters delivered by fl/fl and KO mice (n = 6 per group). F, Number of pups delivered per litter by fl/fl and KO mice (n = 6--7 dams per group, with 2--9 litters per dam). Error bars represent SEM. Student\'s *t* test: *a* = *P* \< .05; *d* = *P* \< .001.](zmg0041351710003){#F3}

The delayed sexual maturation and extended estrous cycle in *Lrh1^Kiss1^*^−/−^ mice suggested a defect in gonadotopin secretion. Indeed, whereas plasma LH levels were normal in *Lrh1^Kiss1^*^−/−^mice ([Figure 4](#F4){ref-type="fig"}A), plasma FSH levels were reduced significantly during both diestrus and estrus ([Figure 4](#F4){ref-type="fig"}B). Conversely, plasma FSH levels were significantly elevated in *Kiss1-Lrh1*-Tg mice as were plasma LH concentrations ([Figure 4](#F4){ref-type="fig"}C). Thus, regulation of *Kiss1* by LRH-1 in the Arc controls pituitary FSH secretion in vivo.

![*Kiss1^Lrh1^*^−/−^ Mice Have Abnormal Follicles. A and B, Serum LH (A) and FSH (B) levels in female *Lrh1^fl/fl^* (fl/fl) and *Lrh1^Kiss1^*^−/−^ knockout (KO) mice in diestrus or estrus (n = 5--8 per group). C, Serum FSH and LH levels in female control and kisspeptin neuron-specific *Lrh1*-Tg mice in diestrus (n = 4 per group). D, Hematoxylin and eosin staining of ovaries (Ov) from fl/fl and KO mice in diestrus or estrus as indicated. 100× magnification, 5-μm sections, scale bars = 100 μm. cl, corpora lutea; g, graafian follicle; cy, follicular cyst. Quantification of follicular cysts (panel E) and corpora lutea (panel F) in ovaries from fl/fl and KO mice (n = sections from 5--8 mice per group). G, Quantification of corpora lutea in superovulated fl/fl and KO mice (n = sections from 3--7 mice per group). H, Plasma E~2~ concentrations in fl/fl and KO mice in diestrus or estrus (n = 5--8 mice per group). Error bars represent SEM. Student\'s *t* test: *a* = *P* \< .05.](zmg0041351710004){#F4}

Ovarian histology confirmed defects consistent with FSH deficiency in *Lrh1^Kiss1^*^−/−^ mice. During diestrus, when early follicular development occurs in a largely FSH-independent manner ([@B39]), there were no histologic differences observed between ovaries from *Lrh1^fl/fl^* and *Lrh1^Kiss1^*^−/−^ mice ([Figure 4](#F4){ref-type="fig"}D). However, in the postovulation estrus phase, *Lrh1^Kiss1^*^−/−^ ovaries contained an abnormal number of unruptured mature follicles and fluid-filled antral follicular cysts ([Figure 4](#F4){ref-type="fig"}, D and E) and fewer corpora lutea ([Figure 4](#F4){ref-type="fig"}F). Notably, there was no difference between *Lrh1^fl/fl^* and *Lrh1^Kiss1^*^−/−^ mice in the number of corpora lutea after superovulation ([Figure 4](#F4){ref-type="fig"}G), demonstrating that this phenotype could be reversed by administration of exogenous gonadotropins. Consistent with the presence of follicular cysts and impaired ovulation, *Lrh1^Kiss1^*^−/−^ mice had elevated plasma E~2~ levels during estrus but not diestrus ([Figure 4](#F4){ref-type="fig"}H). These data demonstrate that deletion of LRH-1 from kisspeptin neurons decreases plasma FSH levels, resulting in aberrant follicular maturation and an impaired LH response.

Discussion
==========

In this report, we demonstrate that LRH-1 regulates *Kiss1* transcription selectively in the Arc of the hypothalamus. Targeted deletion of LRH-1 from Arc kisspeptin neurons decreased *Kiss1* expression, leading to decreased serum FSH levels and impaired follicle maturation and ovulation. Conversely, overexpression of LRH-1 in kisspeptin neurons in the *Kiss1-Lrh1*-Tg line increased *Kiss1* expression and serum FSH levels. Using a combination of ChIP and cell-based reporter assays, we further show that LRH-1 directly regulates *Kiss1* transcription by binding to a consensus response element approximately 200 bp downstream of the TSS. These data demonstrate that LRH-1 in the Arc plays an important role in regulating follicular biology in the ovary. We note that the LRH-1 paralog, steroidogenic factor-1, which binds to the same consensus DNA response element and also regulates female reproduction, is exclusively expressed in the brain in the ventral medial hypothalamic nucleus and thus does not regulate *Kiss1* expression ([@B40]).

Female mice that completely lack FSH signaling are infertile due to arrest of follicular maturation at the preantral stage ([@B39]). In the present study, elimination of LRH-1 from a subpopulation of kisspeptin neurons reduced plasma FSH concentrations 10%--40% depending on cycle phase. Although this level of FSH was sufficient to allow progression to the graafian stage, the follicles display a perturbed LH response that resulted in the formation of follicular cysts and delayed progression of the next estrous cycle. Comparable models of diminished (rather than absent) FSH signaling are limited and in vivo data regarding the precise timing and intensity of FSH signal required for normal follicular maturation are not available. However, evidence from in vitro cultures of primary follicles supports the notion that in order to achieve normal maturation, the intensity of FSH signaling must be precisely coordinated with the developmental stage of the follicle ([@B41], [@B42]). As such, LRH-1 in kisspeptin neurons plays an important role in maintaining plasma FSH at a level that is required for the formation of mature follicles that are fully capable of responding to the midcycle LH surge.

The presence of LRH-1 in kisspeptin neurons in Arc, but not in the AVPV, provides a mechanistic basis for the differential contributions of these kisspeptin neuron populations to pituitary gonadotropin output. The effect of LRH-1 on basal *Kiss1* expression is required for sustaining the levels of FSH needed for normal follicle maturation. Once follicles are mature and plasma E~2~ levels peak, ERα induces *Kiss1* expression in the AVPV (where *Kiss1* is not regulated by LRH-1) to drive the LH surge needed for ovulation. At the same time, Arc *Kiss1* expression is repressed by ERα, which causes the drop in serum FSH observed at the end of the estrous cycle. Importantly, we show that LRH-1 is not required for E~2~-mediated repression of *Kiss1*. Thus, the presence of LRH-1 in the Arc maintains FSH output during diestrus, whereas its absence in the AVPV results in low basal *Kiss1* expression and is permissive for the kisspeptin spike that culminates in the LH surge during estrus. Therefore, LRH-1 in kisspeptin neurons plays an important evolutionary role in maintaining optimal reproductive success and thus conferring species fitness.

An important theme in LRH-1 biology is its role in coordinating metabolic processes among different tissues. For example, in the enterohepatic axis, LRH-1 coordinates bile acid homeostasis by regulating programs of genes in both the intestine and liver ([@B23], [@B24]). Here, we extend this paradigm to include the hypothalamic-pituitary-gonadal axis. In the pituitary, LRH-1 is important for gonadotropin subunit expression ([@B26]), and in the ovary, LRH-1 cooperates with ERα to regulate *Cyp19a1* and progesterone synthesis enzymes in response to gonadotropin hormones ([@B25]). We now show that LRH-1 is also required for regulating kisspeptin in the hypothalamus and downstream gonadotropin levels.
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